Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 359

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

Open access
Dallas, Nikolaos A., Samuel, Shaija, Xia, Ling, Fan, Fan, Gray, Michael J., Lim, Sherry J., Ellis, Lee M.·2008·Clinical Cancer Research

Abstract

Endoglin (CD105) is an accessory protein of the transforming growth factor-β receptor system expressed on vascular endothelial cells. Mutation of the endoglin gene is associated with hereditary hemorrhagic telangiectasias, or Osler-Weber-Rendu syndrome, and has been studied extensively in the context of this disease. The expression of endoglin is elevated on the endothelial cells of healing wounds, developing embryos, inflammatory tissues, and solid tumors. Endoglin is a marker of activated endothelium, and its vascular expression is limited to proliferating cells. Recent studies identified endoglin expression in several solid tumor types, with the level of expression correlating with various clinicopathologic factors including decreased survival and presence of metastases. Attempts to target endoglin and the cells that express this protein in tumor-bearing mice have yielded promising results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-07-4478

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 359

Metadata

Authors
Dallas, N. A., Samuel, S., Xia, L., Fan, F., Gray, M. J., Lim, S. J., & Ellis, L. M.
Venue
Clinical Cancer Research
Published
2008-04-01
Volume
14
Issue
7
Pages
1931-1937
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W1996141843
Cited by
359
References
56
FWCI
7.57
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-07-4478
The paper
Dallas, N. A., Samuel, S., Xia, L., Fan, F., Gray, M. J., Lim, S. J., & Ellis, L. M. (2008). Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-07-4478

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.